Corporate Governance

Ian has more than 30 years of board-level experience in the industrial technology industry and has served as chief executive officer of companies operating in the United States and Europe. Ian was formerly the president of Uniphase Inc, Chairman of Oplink Communications Inc which he took public on the NASDAQ and spent seven years as a partner of Crescendo Ventures llp. Ian founded and since August 2010 has acted as the CEO of Ian Jenks Limited, a consulting company providing consulting services to companies in the industrial technology industry. Ian has been a director of Techstep ASA, a provider of managed mobile services in the Nordics, Paysafe plc., an international provider of payment processing services, and Brady plc, a provider of commodity trading software. He also has served and continues to serve as a director of a number of private companies. Ian received a B.Sc. in Aeronautical Engineering from Bristol University.

Klaas de Boer has served as a member of SmartKem’s board of directors since the Closing of the Exchange. Klaas has been a venture capitalist for more than 20 years, and has served as the Managing Partner of Entrepreneurs Fund Management LLP, a venture capital firm, since January 2008. In that capacity he served on numerous boards, including Lifeline Scientific Inc. and Heliocentris Energy Solutions AG. He currently chairs AIM listed Xeros Technology Group plc, and General Fusion, Inc., and serves on the boards of vasopharm GmbH and D3O Holdings Ltd. Klaas received his M.Sc. degree in Applied Physics from Delft University of Technology and his M.B.A. from INSEAD.

Steven is a Professor of Materials and Electrical and Computer Engineering as well as the Executive Director of the Solid State Lighting and Energy Electronics Center at the University of California, Santa Barbara. Steven has previously worked at the Hewlett-Packard Optoelectronics team. He has been a Director on the Board of several startup companies which include Soraa Laser Diode, Akoustis Technologies and Aeluma Inc.

Barbra Keck was formerly the Chief Financial Officer of Deverra Therapeutics, Inc., a developer of cell therapies. Prior to that, she held positions of increasing responsibility at Delcath Systems, Inc., a Nasdaq-listed interventional oncology company, starting as Controller in 2009 and ultimately becoming chief financial officer in February 2017, a position which she held until 2020.